Company intelligence / Profile preview

Omneuron

Menlo Park, California, United Statesomneuron.com ↗

Ownership: Private
Development stage: Other

Overview

Omneuron has developed a non-invasive neuroimaging therapy platform that uses real-time fMRI to help patients visualize and learn to control activation in specific brain regions associated with chronic pain. In published studies, this approach led to significant reductions in reported pain among chronic pain patients. The technology remains investigational and has not received FDA clearance for therapeutic use.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Stanford University School of MedicineNational Institutes of Health funding/support

Beyond the preview

Go deeper on Omneuron.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omneuron.

Explore the full profile